<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A human <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, positive for the Epstein-Barr virus (EBV)-associated nuclear antigen, was recently established from a North American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This cell line, SU-AmB-2, contained EBV DNA both in the form of circular, nonintegrated DNA molecules of <z:mp ids='MP_0001799'>viral</z:mp> genome length, present in multiple copies per cell, and as integrated sequences </plain></SENT>
<SENT sid="2" pm="."><plain>Having DNA present in both of these forms, it resembled cell lines established from African Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In studies on EBV strain differences, the episomal <z:mp ids='MP_0001799'>viral</z:mp> DNA in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells may now be compared with <z:mp ids='MP_0001799'>viral</z:mp> DNA in nonmalignant cells with the use of cell lines from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients of similar geographic origin </plain></SENT>
</text></document>